Immune Checkpoint Inhibitors


Cancer Immunotherapy Likely Safe for those with Chronic Infections Reports Georgetown University Retrospective Study

A retrospective study driven by Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, found that cancer patients battling viral infections such as HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) shouldn’t be precluded from immune...

Therapy Advancements and Biomarker Identifications Leading to Improved Ability to Predict and Enhance Responses To Immunotherapeutic Agents In Non–Small Cell Lung Cancer (NSCLC)

Targeted therapy advancements and the identification of emerging biomarkers of response to treatment have led to an improved ability to predict and enhance responses to immunotherapeutic agents in non–small cell lung cancer (NSCLC). Available agents that have...

Pin It on Pinterest